97 related articles for article (PubMed ID: 8823451)
21. Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts.
Körbling M; Champlin R
Stem Cells; 1996 Mar; 14(2):185-95. PubMed ID: 8991538
[TBL] [Abstract][Full Text] [Related]
22. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
23. The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support.
Benjamin RJ; Linsley L; Axelrod JD; Churchill WH; Sieff C; Shulman LN; Elias A; Ayash L; Malachowski ME; Uhl L
Transfusion; 1995 Oct; 35(10):837-44. PubMed ID: 7570914
[TBL] [Abstract][Full Text] [Related]
24. Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor.
Passos-Coelho JL; Ross AA; Kahn DJ; Moss TJ; Davis JM; Huelskamp AM; Noga SJ; Davidson NE; Kennedy MJ
J Clin Oncol; 1996 Sep; 14(9):2569-75. PubMed ID: 8823337
[TBL] [Abstract][Full Text] [Related]
25. Automated programs for collection of mononuclear cells and progenitor cells by two separators for peripheral blood progenitor cell transplantation: comparison by a randomized crossover study.
Ikeda K; Ohto H; Kanno T; Ogata T; Noji H; Ogawa K; Maruyama Y
Transfusion; 2007 Jul; 47(7):1234-40. PubMed ID: 17581158
[TBL] [Abstract][Full Text] [Related]
26. Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation.
Larrea L; de la Rubia J; Soler MA; Ribas P; Fernández JM; Picón I; García-Boyero R; García-Bellés C; Roig R
Haematologica; 2004 Oct; 89(10):1232-7. PubMed ID: 15477209
[TBL] [Abstract][Full Text] [Related]
27. Peripheral blood progenitor cells: a replacement for marrow transplantation?
Champlin RE
Semin Oncol; 1996 Apr; 23(2 Suppl 4):15-21. PubMed ID: 8600543
[TBL] [Abstract][Full Text] [Related]
28. Concentration of citrate anticoagulant in peripheral blood progenitor cell collections.
Burger SR; Fautsch SK; Stroncek DF; McCullough J
Transfusion; 1996 Sep; 36(9):798-801. PubMed ID: 8823453
[TBL] [Abstract][Full Text] [Related]
29. Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant.
Majado MJ; García-Hernández A; Morales A; González C; Martínez-Sánchez V; Menasalvas A; Rosique P; Rubio A; Sanz-Imedio E
Bone Marrow Transplant; 2007 Jan; 39(2):121-5. PubMed ID: 17173054
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
[TBL] [Abstract][Full Text] [Related]
31. Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.
Tepler I; Cannistra SA; Frei E; Gonin R; Anderson KC; Demetri G; Niloff J; Goodman H; Muntz H; Muto M
J Clin Oncol; 1993 Aug; 11(8):1583-91. PubMed ID: 8101563
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte-colony-stimulating factor: implications for yield of hematopoietic progenitor cell collections.
Webb IJ; Eickhoff CE; Elias AD; Ayash LJ; Wheeler CA; Schwartz GN; Demetri GD; Anderson KC
Transfusion; 1996 Feb; 36(2):160-7. PubMed ID: 8614968
[TBL] [Abstract][Full Text] [Related]
33. Autologous transplantation of peripheral blood progenitor cells mobilized by chemotherapy with or without G-CSF (filgrastim) in resistant lymphoproliferative diseases: enhanced hemopoietic recovery with filgrastim primed progenitors.
Sica S; Salutari P; Di Mario A; Rutella S; Ortu-LaBarbera E; Storti S; De Stefano V; Menichella G; Pierelli L; Zini G
Haematologica; 1993; 78(6):383-8. PubMed ID: 7513675
[TBL] [Abstract][Full Text] [Related]
34. The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
Elias AD; Ayash L; Tepler I; Wheeler C; Schwartz G; Mazanet R; Schnipper L; Frei E; Antman K
J Hematother; 1993; 2(3):377-82. PubMed ID: 7522891
[TBL] [Abstract][Full Text] [Related]
35. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
36. Immunomagnetic selection of progenitor cells from peripheral blood after thawing with an automatic system in a pediatric patient with a neuroblastoma.
Zinno F; Landi F; Aureli V; Donfrancesco A; Isacchi G
Transfusion; 2008 Mar; 48(3):550-2. PubMed ID: 18067494
[TBL] [Abstract][Full Text] [Related]
37. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
[TBL] [Abstract][Full Text] [Related]
38. Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation.
Friedman J; Lazarus HM; Koç ON
Bone Marrow Transplant; 2000 Oct; 26(8):831-6. PubMed ID: 11081381
[TBL] [Abstract][Full Text] [Related]
39. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products.
Padley DJ; Dietz AB; Gastineau DA
Transfusion; 2007 Apr; 47(4):636-43. PubMed ID: 17381622
[TBL] [Abstract][Full Text] [Related]
40. A randomized study of multi-day infusion of autologous peripheral blood progenitor cells.
Abdel-Razeq H; Pohlman B; Andresen S; Kalaycio M; Overmoyer B; Wise K; Dannley R; DeMars D; Goormastic M; Bolwell B
Bone Marrow Transplant; 1998 Feb; 21(3):221-3. PubMed ID: 9489643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
